Helping parents and children with cancer make treatment decisions
Official title: Effectiveness Evaluation on the Decision Preferences and Decision Support Intervention of Minor Cancer Patients and Their Parents
Run by Kaohsiung Medical University Chung-Ho Memorial Hospital · NCT06651242 · Data updated 2026-11-12
This study is trying to see if giving parents and their kids with cancer better information can help them make treatment decisions together.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years to 20 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Kaohsiung Medical University Chung-Ho Memorial Hospital Academic / other |
| Locations | 1 site (Kaohsiung City) |
| Status | Recruiting |
| Started | October 26, 2022 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | August 28, 2025 |
| Trial ID | NCT06651242 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include parents over 20 years old with a child under 20 diagnosed with cancer who can communicate in Mandarin or Taiwanese.
✕Probably not a fit
Patients who may not benefit include those with mental health disorders or those whose guardians are unwilling to inform them of their diagnosis.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to understand the information needs of parents with children diagnosed with cancer when making treatment decisions. It involves developing a localized version of the Control Preferences Scale to aid in decision-making. The effectiveness of involving both minor cancer patients and their parents in the decision-making process will be evaluated through the implementation of decision-making information aids alongside routine care.
Why it matters
Potential benefit: If successful, this intervention could empower families to make more informed and collaborative treatment decisions for pediatric cancer.
How similar studies have gone: Other studies have shown success in similar approaches of involving families in pediatric treatment decisions, indicating potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion Criteria for Parents: 1. Age over 20 years. 2. Child under 20 years old, diagnosed with cancer by a doctor. 3. their child know her/his cancer diagnosis. 4. Agree to have the child participate in family meeting and have ability to communicate in Mandarin or Taiwanese. * Inclusion Criteria for Minors: 1. Aged between 7 and 20 years, diagnosed with pediatrtic cancer. 2. Aware of their cancer diagnosis. 3. Able to express their thoughts to the researcher in Mandarin or Taiwanese. 4. Both the minor and their legal guardian consent to participate in the study. Exclusion Criteria: 1. Diagnosed with depression, and/or anxiety, and/or other mental disorders. 2. Legal guardian is unwilling to inform the minor of their diagnosis. 3. Minor is unwilling to share their thoughts with their parents.
Where it's running
-
Kaohsiung Medical University
Kaohsiung City, Taiwan Recruiting
Study contacts
- Study coordinator: Li-Min Wu, PhD
- Email: painting@kmu.edu.tw
- Phone: (886)73121101
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Smoky Futures: Danish Adolescent Nicotine Use over Time
This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes
This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.
-
Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children
This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.